Papers by Dieter Willbold · AgingResearch.News

Alzheimer's Research & Therapy29 Sep
Fecal Aβ and tau aggregates are elevated in cognitive impairment and reveal peripheral proteopathic alterations
Case-control study in peopleCognitive impairment
Paper
European Journal of Pharmaceutical Sciences3 Sep
Pharmacokinetic properties of the clinical drug candidate PRI-002 with regard to genotype, sex, age, dose-dependence and food effects in mice
Experiments in animalsInterventions
Paper
AAIC 2025 Abstract26 Dec
PRImus‐AD study: Design of the phase 2 study treating patients with MCI or mild dementia due to Alzheimer’s disease (AD) with the orally available PRI‐002
Trial in peopleInterventions
Paper
AAIC 2025 Abstract26 Dec
Results of a randomized, placebo‐controlled phase 1b study in MCI and mild AD patients with the orally available PRI‐002 with a unique mode of action.
Trial in peopleInterventions
Paper

AAIC 2025 Abstract23 Dec
Anti‐oligomeric PRI‐002 does not cause ARIA‐E in an ongoing Phase 2 trial
Trial in peopleInterventions
Paper